Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Romics

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Urologia Internationalis|April 5, 2007
Analysis of risk factors for urinary incontinence after radical prostatectomyAttila Majoros, Dietmar Bach, Attila Keszthelyi, et al.
Pathology Oncology Research : POR|September 23, 2008
Serum levels of angiogenic factors and their prognostic relevance in bladder cancerTibor Szarvas, Tobias Jäger, Falk Droste, et al.
Orvosi Hetilap|August 16, 2002
[The role of repeated biopsies in prognosis of prostate cancer]Imre Romics, Sándor Lovász, János Szabó, et al.
European Urology|March 24, 2004
Genetic profile of bone metastases in renal cell carcinomaKerstin Junker, Imre Romics, Attila Szendroi, et al.
International Urology and Nephrology|May 9, 2015
Changes of protein expression in prostate cancer having lost its androgen sensitivityGergely Bánfi, Ivett Teleki, Péter Nyirády, et al.
The Journal of Urology|February 11, 2003
T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-GuerinBjoern G Volkmer, Jürgen E Gschwend, Simone H Maier, et al.
The Canadian Journal of Urology|June 28, 2011
The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancerAttila Szendroi, Gabor Speer, Adam Tabak, et al.
Pathology Oncology Research : POR|December 25, 2016
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific SurvivalChristian Niedworok, Stephan Tschirdewahn, Henning Reis, et al.
Orvosi Hetilap|September 3, 2010
[Effects of bioactive molecules of Beta vulgaris L. ssp. esculenta var. rubra on metastatic prostate cancer]Péter Nyirády, Eva Sárdi, Gabriella Beko, et al.
International Journal of Cancer|August 5, 2011
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancerTibor Szarvas, Viktória László, Frank Vom Dorp, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Urologia Internationalis|April 5, 2007
Analysis of risk factors for urinary incontinence after radical prostatectomyAttila Majoros, Dietmar Bach, Attila Keszthelyi, et al.
Pathology Oncology Research : POR|September 23, 2008
Serum levels of angiogenic factors and their prognostic relevance in bladder cancerTibor Szarvas, Tobias Jäger, Falk Droste, et al.
Orvosi Hetilap|August 16, 2002
[The role of repeated biopsies in prognosis of prostate cancer]Imre Romics, Sándor Lovász, János Szabó, et al.
European Urology|March 24, 2004
Genetic profile of bone metastases in renal cell carcinomaKerstin Junker, Imre Romics, Attila Szendroi, et al.
International Urology and Nephrology|May 9, 2015
Changes of protein expression in prostate cancer having lost its androgen sensitivityGergely Bánfi, Ivett Teleki, Péter Nyirády, et al.
The Journal of Urology|February 11, 2003
T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-GuerinBjoern G Volkmer, Jürgen E Gschwend, Simone H Maier, et al.
The Canadian Journal of Urology|June 28, 2011
The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancerAttila Szendroi, Gabor Speer, Adam Tabak, et al.
Pathology Oncology Research : POR|December 25, 2016
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific SurvivalChristian Niedworok, Stephan Tschirdewahn, Henning Reis, et al.
Orvosi Hetilap|September 3, 2010
[Effects of bioactive molecules of Beta vulgaris L. ssp. esculenta var. rubra on metastatic prostate cancer]Péter Nyirády, Eva Sárdi, Gabriella Beko, et al.
International Journal of Cancer|August 5, 2011
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancerTibor Szarvas, Viktória László, Frank Vom Dorp, et al.
Pageof 8